Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Keenova Therapeutics plc | 139,149 | reported | 16 Mar 2016 | tx 38+723,985−1,392,724 |
| STAAR SURGICAL CO | 98,137 | reported | 15 May 2013 | tx 49+240,739−141,850 |
| Lineage Cell Therapeutics, Inc. | 75,000 | reported | 01 Jul 2024 | tx 8+361,155−100,000 |
| Asterias Biotherapeutics, Inc. | 75,000 | reported | 21 Jun 2018 | tx 5+357,352 |
| COMARCO INC | 66,859 | reported | 11 Jun 2007 | tx 18+128,625−135,277 |
| Insight Molecular Diagnostics Inc. | 20,000 | reported | 15 Jun 2017 | tx 4+277,289 |
| QUESTCOR PHARMACEUTICALS INC | 0 | reported | 14 Aug 2014 | tx 243+5,259,397−4,841,172 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jul 2024 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 08 Feb 2024 | PURCHASE | Lineage Cell Therapeutics, Inc. | 96,155 | 1.04 USD | first after silence |
| 01 Jul 2023 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 01 Jul 2020 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 01 Jul 2019 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 19 Mar 2019 | GRANT_AWARD | Lineage Cell Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 21 Jun 2018 | GRANT_AWARD | Asterias Biotherapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 15 Jun 2017 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jun 2017 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 6,520 | 0.00 USD | deriv |
| 30 Mar 2017 | GRANT_AWARD | Asterias Biotherapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 17 Oct 2016 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 230,769 | 0.00 USD | deriv |
| 29 Aug 2016 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 20,000 | 0.00 USD | deriv |
| 13 May 2016 | PURCHASE | Asterias Biotherapeutics, Inc. | 88,235 | 3.39 USD | first after silence |
| 13 May 2016 | PURCHASE | Asterias Biotherapeutics, Inc. | 44,117 | 0.01 USD | deriv |
| 16 Mar 2016 | TAX_WITHHOLDING | Keenova Therapeutics plc | 458 | 55.69 USD | |
| 28 Feb 2016 | GRANT_AWARD | Asterias Biotherapeutics, Inc. | 75,000 | 0.00 USD | deriv |
| 13 May 2015 | EXERCISE | Keenova Therapeutics plc | 51,417 | 26.95 USD | |
| 13 May 2015 | SALE | Keenova Therapeutics plc | 1,400 | 123.18 USD | |
| 13 May 2015 | SALE | Keenova Therapeutics plc | 50,017 | 122.43 USD | |
| 13 May 2015 | EXERCISE | Keenova Therapeutics plc | 51,417 | 0.00 USD | deriv |
| 13 Apr 2015 | SALE | Keenova Therapeutics plc | 900 | 129.21 USD | |
| 13 Apr 2015 | SALE | Keenova Therapeutics plc | 11,560 | 128.19 USD | |
| 13 Apr 2015 | EXERCISE | Keenova Therapeutics plc | 40,000 | 26.95 USD |
4 purchases reported after at least 12 months of silence — most recent on 08 Feb 2024.